Adult Diseases and Low-Grade Systemic Inflammation Have Their Origins in the Perinatal Period

  • Undurti N. Das


It is evident from the discussion in the preceding chapters on various diseases/disorders that low-grade systemic inflammation plays a significant role in the pathobiology of obesity, hypertension, type 2 diabetes mellitus, dyslipidemia, atherosclerosis, coronary heart disease, cancer, aging, Alzheimer’s disease, schizophrenia, depression, dementia and even stroke (though this disease was not discussed in details, in general, it occurs as a result of underlying hypertension, diabetes mellitus, hyperlipidemia and hence, could be considered as a consequence of these diseases rather than as a separate disease entity). The presence of low-grade systemic inflammation as evidenced by increased plasma levels of CRP, IL-6, TNF-α, HMGB-1, MIF, ROS, iNO, and a concomitant decrease in anti-inflammatory cytokines such as IL-4, IL-10, IL-12, TGF-β, and anti-oxidants, and decreased plasma and tissue levels of various PUFAs such as AA, EPA, DHA, GLA, DGLA and their anti-inflammatory products such as lipoxins, resolvins, protectins and maresins may underlie all these diseases. Thus, an imbalance between pro- and anti-inflammatory molecules seems to be a common feature in these diseases. Thus, the molecular events in all these diseases are similar but the target tissues are different. This implies that methods designed to suppress the production of pro-inflammatory molecules and/or increase in the synthesis and secretion of anti-inflammatory molecules could be of benefit in their prevention and management (Fig. 16.1).


Metabolic Syndrome Arachidonic Acid Perinatal Period Brain Growth Hypothalamic Neuron 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. [1]
    Das UN (2011) Influence of polyunsaturated fatty acids and their metabolites on stem cell biology. Nutrition 27:21–25 PubMedGoogle Scholar
  2. [2]
    Barker DJP (ed) (1992) Fetal and infant origins of adult disease. BMJ Publishing, LondonGoogle Scholar
  3. [3]
    Robinson R (2001) The fetal origins of adult disease. BMJ 322:375–376PubMedGoogle Scholar
  4. [4]
    Das UN (2002) A perinatal strategy for preventing adult disease. The role of polyunsaturated fatty acids. Kluwer Academic, NorwellGoogle Scholar
  5. [5]
    Das UN (2010) Metabolic syndrome pathophysiology. The role of essential fatty acids. Wiley-Blackwell, AmesGoogle Scholar
  6. [6]
    Matsuzaka T, Shimano H, Yahagi N, Amemiya-Kudo M, Yoshikawa T, Hasty AH, Tamura Y, Osuga J, Okazaki H, Iizuka Y, Takahashi A, Sone H, Gotoda T, Ishibashi S, Yamada N (2002) Dual regulation of mouse Delta(5)- and Delta(6)-desaturase gene expression by SREBP-1 and PPARalpha. J Lipid Res 43:107–114PubMedGoogle Scholar
  7. [7]
    Das UN (2006) Essential fatty acids: biochemistry, physiology, and pathology. Biotechnol J 1:420–439PubMedGoogle Scholar
  8. [8]
    Das UN (2006) Biological significance of essential fatty acids. J Assoc Physicians India 54:309–319PubMedGoogle Scholar
  9. [9]
    Auestad N, Scott DT, Janowsky JS, Jacobson C, Carroll RE, Montalto MB, Halter R, Qiu W, Jacobs JR, Connor WE, Conner SL, Taylor JA, Neuringer M, Fitzgerald KM, Hall RT (2003) Visual, cognitive, and language assessments at 39 months: a follow-up study of children fed formulas containing long-chain polyunsaturated fatty acids to 1 year of age. Pediatrics 112(3 Pt 1):e177–e183Google Scholar
  10. [10]
    Fewtrell MS, Morley R, Abbott RA, Singhal A, Isaacs EB, Stephenson T, MacFadyen U, Lucas A (2002) Double-blind, randomized trial of long-chain polyunsaturated fatty acid supplementation in formula fed to preterm infants. Pediatrics 110(1 Pt 1):73–82PubMedGoogle Scholar
  11. [11]
    SanGiovanni JP, Parra-Cabrera S, Colditz GA, Berkey CS, Dwyer JT (2000) Meta-analysis of dietary essential fatty acids and long-chain polyunsaturated fatty acids as they relate to visual resolution acuity in healthy preterm infants. Pediatrics 105:1292–1298PubMedGoogle Scholar
  12. [12]
    O’Connor DL, Hall R, Adamkin D, Auestad N, Castillo M, Connor WE, Connor SL, Fitzgerald K, Groh-Wargo S, Hartmann EE, Jacobs J, Janowsky J, Lucas A, Margeson D, Mena P, Neuringer M, Nesin M, Singer L, Stephenson T, Szabo J, Zemon V, Ross Preterm Lipid Study (2001) Growth and development in preterm infants fed long-chain polyunsaturated fatty acids: a prospective, randomized controlled trial. Pediatrics 108:359–371PubMedGoogle Scholar
  13. [13]
    Boehm G, Borte M, Bohles HJ, Muller H, Kohn G, Moro G (1996) Docosahexaenoic and arachidonic acid content of serum and red blood cell membrane phospholipids of preterm infants fed breast milk, standard formula or formula supplemented with n-3 and n-6 long-chain polyunsaturated fatty acids. Eur J Pediatr 155:410–416PubMedGoogle Scholar
  14. [14]
    Fewtrell MS, Abbott RA, Kennedy K, Singhal A, Morley R, Caine E, Jamieson C, Cockburn F, Lucas A (2004) Randomized, double-blind trial of long-chain polyunsaturated fatty acid supplementation with fish oil and borage oil in preterm infants. J Pediatr 144:471–479PubMedGoogle Scholar
  15. [15]
    Willatts P, Forsyth JS, DiModugno MK, Varma S, Colvin M (1998) Effect of long-chain polyunsaturated fatty acids in infant formula on problem solving at 10 months of age. Lancet 352:688–691PubMedGoogle Scholar
  16. [16]
    Salem N Jr, Wegher B, Mena P, Uauy R (1996) Arachidonic and docosahexaenoic acids are biosynthesized from their 18-carbon precursors in human infants. Proc Natl Acad Sci U S A 93:49–54PubMedGoogle Scholar
  17. [17]
    Farquharson J, Jamieson EC, Abbasi KA, Patrick WJA, Logan RW, Cockburn F (1995) Effect of diet on the fatty acid composition of the major phospholipids of infant cerebral cortex. Arch Dis Child 72:198–203PubMedGoogle Scholar
  18. [18]
    Ryan AS, Astwood JD, Gautier S, Kuratko CN, Nelson EB, Salem N Jr (2010) Effects of long-chain polyunsaturated fatty acid supplementation on neurodevelopment in childhood: a review of human studies. Prostaglandins Leukot Essent Fatty Acids 82:305–314PubMedGoogle Scholar
  19. [19]
    Auestad N, Scott DT, Janowsky JS, Jacobsen C, Carroll RE, Montalto MB, Halter R, Qiu W, Jacobs JR, Connor WE, Connor SL, Taylor JA, Neuringer M, Fitzgerald KM, Hall RT (2003) Visual, cognitive, and language assessments at 39 months: a follow-up study of children fed formulas containing long-chain polyunsaturated fatty acids to 1 year of age. Pediatrics 112(3 Pt 1):e177–e183PubMedGoogle Scholar
  20. [20]
    Chang CY, Ke DS, Chen JY (2009) Essential fatty acids and human brain. Acta Neurol Taiwan 18:231–241PubMedGoogle Scholar
  21. [21]
    Makrides M, Smithers LG, Gibson RA (2010) Role of long-chain polyunsaturated fatty acids in neurodevelopment and growth. Nestle Nutr Workshop Ser Pediatr Program 65:123–133PubMedGoogle Scholar
  22. [22]
    Yu N, Martin J-L, Stella N, Magistretti PJ (1993) Arachidonic acid stimulates glucose uptake in cerebral cortical astrocytes. Proc Natl Acad Sci U S A 90:4042–4046PubMedGoogle Scholar
  23. [23]
    Goetzl EJ, Goldman DW, Naccache PH, Sha’afi RI, Pickett WC (1982) Mediation of leukocyte components of inflammatory reactions by lipoxygenase products of arachidonic acid. Adv Prostaglandin Thromboxane Leukot Res 9:273–282PubMedGoogle Scholar
  24. [24]
    Fong JC, Chen CC, Liu D, Chai SP, Tu MS, Chu KY (1996) Arachidonic acid stimulates the intrinsic activity of ubiquitous glucose transporter (GLUT1) in 3T3-L1 adipocytes by a protein kinase C-independent mechanism. Cell Signal 8:179–183PubMedGoogle Scholar
  25. [25]
    Butler M, Huzel N, Barnabé N (1997) Unsaturated fatty acids enhance cell yields and perturb the energy metabolism of an antibody-secreting hybridoma. Biochem J 322(Pt 2):615–623PubMedGoogle Scholar
  26. [26]
    Garber K (2010) Oncology’s energetic pipeline. Nat Biotechnol 18:888–891Google Scholar
  27. [27]
    Chiou GY, Fong JC (2005) Synergistic effect of prostaglandin F2alpha and cyclic AMP on glucose transport in 3T3-L1 adipocytes. J Cell Biochem 94:627–634PubMedGoogle Scholar
  28. [28]
    Ragozzino ME, Unick KE, Gold PE (1996) Hippocampal acetylcholine release during memory testing in rats: augmentation by glucose. Proc Natl Acad Sci U S A 93:4693–4698PubMedGoogle Scholar
  29. [29]
    Das UN (2002) Alcohol consumption and risk of dementia. Lancet 360:490PubMedGoogle Scholar
  30. [30]
    Minami M, Kimura S, Endo T, Hamaue N, Horafuji M, Togashi H, Matsumoto M, Yaoshioka M, Saito H, Watanabe S, Kobayashi T, Okuyama H (1997) Dietary docosahexaenoic acid increases cerebral acetylcholine levels and improves passive avoidance performance in stroke-prone spontaneously hypertensive rats. Pharmacol Biochem Behav 58:1123–1129PubMedGoogle Scholar
  31. [31]
    Hersi AI, Kitaichi K, Srivastava LK, Gaudreau P, Quirion R (2000) Dopamine D-5 receptor modulates hippocampal acetylcholine release. Brain Res Mol Brain Res 76:336–340PubMedGoogle Scholar
  32. [32]
    Wang G-J, Volkow ND, Logan J, Pappas NR, Wong CT, Zhu W, Netusil N, Fowler JS (2001) Brain dopamine and obesity. Lancet 357:354–357PubMedGoogle Scholar
  33. [33]
    Abott MA, Wells DG, Fallon JR (1999) The insulin receptor tyrosine kinase substrate p58/53 and the insulin receptor are components of CNS synapses. J Neurosci 19:7300–7308Google Scholar
  34. [34]
    Venters HD, Dantzer R, Kelley KW et al (2000) A new concept in neurodegeneration: TNFalpha is a silencer of survival signals. Trends Neurosci 23:175–180PubMedGoogle Scholar
  35. [35]
    Venters HD, Tang Q, Liu Q et al (1999) A new mechanism of neurodegeneration: proinflammatory cytokine inhibits receptor signaling by a survival peptide. Proc Natl Acad Sci U S A 96:9879–9884PubMedGoogle Scholar
  36. [36]
    Lauritzen I, Blondeau N, Heurteaux C, Widmann C, Romey G, Lazdunski M (2000) Polyunsaturated fatty acids are potent neuroprotectors. EMBO J 19:1784–1793PubMedGoogle Scholar
  37. [37]
    Wang X, Zhao X, Mao ZY, Wang XM, Liu ZL (2003) Neuroprotective effect of docosahexaenoic acid on glutamate-induced cytotoxicity in rat hippocampal cultures. Neuroreport 14:2457–2461PubMedGoogle Scholar
  38. [38]
    Cao D, Xue R, Xu J, Liu Z (2005) Effects of docosahexaenoic acid on the survival and neurite outgrowth of rat cortical neurons in primary cultures. J Nutr Biochem 16:538–546PubMedGoogle Scholar
  39. [39]
    Hogyes E, Nyakas C, Kiliaan A, Farkas T, Penke B, Luiten PG (2003) Neuroprotective effect of developmental docosahexaenoic acid supplement against excitotoxic brain damage in infant rats. Neuroscience 119:999–1012PubMedGoogle Scholar
  40. [40]
    Lonergan PE, Martin DS, Horrobin DF, Lynch MA (2002) Neuroprotective effect of eicosapentaenoic acid in hippocampus of rats exposed to gamma-irradiation. J Biol Chem 277:20804–20811PubMedGoogle Scholar
  41. [41]
    Das UN, Rao KP (2006) Effect of γ-linolenic acid and prostaglandins E1 on gamma-radiation and chemical-induced genetic damage to the bone marrow cells of mice. Prostaglandins Leukot Essent Fatty Acids 74:165–173PubMedGoogle Scholar
  42. [42]
    Kumar SG, Das UN (1994) Effect of prostaglandins and their precursors on the proliferation of human lymphocytes and their secretion of tumor necrosis factor and various interleukins. Prostaglandins Leukot Essent Fatty Acids 50:331–334PubMedGoogle Scholar
  43. [43]
    Kumar SG, Das UN, Kumar KV, Tan BKH, Das NP (1992) Effect of n-6 and n-3 fatty acids on the proliferation and secretion of TNF and IL-2 by human lymphocytes in vitro. Nutr Res 12:815–823Google Scholar
  44. [44]
    Endres S, Ghorbani R, Kelley VE et al (1989) The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 320:265–271PubMedGoogle Scholar
  45. [45]
    Kuboki K, Jiang ZY, Takahara N, Ha SW, Igarashi M, Yamauchi T, Feener EP, Herbert TP, Rhodes CJ, King GL (2000) Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: a specific vascular action of insulin. Circulation 101:676–681PubMedGoogle Scholar
  46. [46]
    Das UN (1994) Beneficial effect of eicosapentaenoic and docosahexaenoic acids in the management of systemic lupus erythematosus and its relationship to the cytokine network. Prostaglandins Leukot Essent Fatty Acids 51:207–213PubMedGoogle Scholar
  47. [47]
    Satomi N, Sakurai A, Haranaka K (1985) Relationship of hypoglycemia to tumor necrosis factor production and antitumor activity: role of glucose, insulin and macrophages. J Natl Cancer Inst 74:1255–1260PubMedGoogle Scholar
  48. [48]
    Boichot E, Sannomiya P, Escofier N et al (1999) Endotoxin-induced acute lung injury in rats: role of insulin. Pulm Pharmacol Ther 12:285–290PubMedGoogle Scholar
  49. [49]
    Guidot DM, Hybertson BM, Kitlowski RP, Repine JE (1996) Inhaled nitric oxide prevents IL-1 induced neutrophil accumulation and associated acute edema in isolated rats lungs. Am J Physiol 271:L225–L229PubMedGoogle Scholar
  50. [50]
    Suresh Y, Das UN (2003) Long-chain polyunsaturated fatty acids and chemically induced diabetes mellitus: effect of ω-3 fatty acids. Nutrition 19:213–228PubMedGoogle Scholar
  51. [51]
    Vecchione C, Aretini A, Maffei A, Marino G, Selvetella G, Poulet R, Trimarco V, Frati G, Lembo G (2003) Cooperation between insulin and leptin in the modulation of vascular tone. Hypertension 42:166–170PubMedGoogle Scholar
  52. [52]
    Nilsson L, Sara VR, Norberg A (1988) Insulin-like growth factor 1 stimulates the release of acetylcholine from rat cortical slices. Neurosci Lett 88:221–226PubMedGoogle Scholar
  53. [53]
    Napoli I, Blusztajn JK, Mellott TJ (2008) Prenatal choline supplementation in rats increases the expression of IGF2 and its receptor IGF2R and enhances IGF2-induced acetylcholine release in hippocampus and frontal cortex. Brain Res 1237:124–135PubMedGoogle Scholar
  54. [54]
    Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, Watkins LR, Wang H, Abumrad N, Eaton JW, Tracey KJ (2000) Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405:458–462PubMedGoogle Scholar
  55. [55]
    Xu Z, Tong C, Eisenach JC (1996) Acetylcholine stimulates the release of nitric oxide from rat spinal cord. Anesthesiology 85:107–111PubMedGoogle Scholar
  56. [56]
    Ponnala S, Rao KP, Chaudhury JR, Ahmed J, Rama Rao B, Kanjilal S, Hasan Q, Das UN (2009) Effect of polyunsaturated fatty acids on diphenyl hydantoin-induced genetic damage in vitro and in vivo. Prostaglandins Leukot Essent Fatty Acids 80:43–50PubMedGoogle Scholar
  57. [57]
    Das UN, Ramadevi G, Rao KP, Rao MS (1985) Prostaglandins and their precursors can modify genetic damage-induced by gamma-radiation and benzo(a)pyrene. Prostaglandins 29:911–920PubMedGoogle Scholar
  58. [58]
    Krishna Mohan I, Das UN (2001) Prevention of chemically induced diabetes mellitus in experimental animals by polyunsaturated fatty acids. Nutrition 17:126–151PubMedGoogle Scholar
  59. [59]
    Suresh Y, Das UN (2003) Long-chain polyunsaturated fatty acids and chemically induced diabetes mellitus: effect of omega-6 fatty acids. Nutrition 19:93–114PubMedGoogle Scholar
  60. [60]
    Suresh Y, Das UN (2003) Long-chain polyunsaturated fatty acids and chemically induced diabetes mellitus. Effect of omega-3 fatty acids. Nutrition 19:213–228PubMedGoogle Scholar
  61. [61]
    Suresh Y, Das UN (2001) Protective action of arachidonic acid against alloxan-induced cytotoxicity and diabetes mellitus. Prostaglandins Leukot Essent Fatty Acids 64:37–52PubMedGoogle Scholar
  62. [62]
    Ferrari D, Cysneiros RM, Scorza CA, Arida RM, Cavalheiro EA, de Almeida AC, Scorza FA (2008) Neuroprotective activity of omega-3 fatty acids against epilepsy-induced hippocampal damage: quantification with immunohistochemical for calcium-binding proteins. Epilepsy Behav 13:36–42PubMedGoogle Scholar
  63. [63]
    Das UN (2008) Essential fatty acids and their metabolites could function as endogenous HMG-CoA reductase and ACE enzyme inhibitors, anti-arrhythmic, anti-hypertensive, anti-atherosclerotic, anti-inflammatory, cytoprotective, and cardioprotective molecules. Lipids Health Dis 7:37PubMedGoogle Scholar
  64. [64]
    Belayev L, Khoutorova L, Atkins KD, Bazan NG (2009) Robust docosahexaenoic acid-mediated neuroprotection in a rat model of transient, focal cerebral ischemia. Stroke 40:3121–3126PubMedGoogle Scholar
  65. [65]
    Bazan NG (2009) Neuroprotectin D1-mediated anti-inflammatory and survival signaling in stroke, retinal degenerations, and Alzheimer’s disease. J Lipid Res 50(Suppl):S400–S405PubMedGoogle Scholar
  66. [66]
    Pan HC, Kao TK, Ou YC, Yang DY, Yen YJ, Wang CC, Chuang YH, Liao SL, Raung SL, Wu CW, Chiang AN, Chen CJ (2009) Protective effect of docosahexaenoic acid against brain injury in ischemic rats. J Nutr Biochem 20:715–725PubMedGoogle Scholar
  67. [67]
    Cao DH, Xu JF, Xue RH, Zheng WF, Liu ZL (2004) Protective effect of chronic ethyl docosahexaenoate administration on brain injury in ischemic gerbils. Pharmacol Biochem Behav 79:651–659PubMedGoogle Scholar
  68. [68]
    Bazan NG (2005) Neuroprotectin D1 (NPD1): a DHA-derived mediator that protects brain and retina against cell injury-induced oxidative stress. Brain Pathol 15:159–166PubMedGoogle Scholar
  69. [69]
    Mukherjee PK, Marcheselli VL, Serhan CN, Bazan NG (2004) Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc Natl Acad Sci U S A 101:8491–8496PubMedGoogle Scholar
  70. [70]
    Gleissman H, Yang R, Martinod K, Lindskog M, Serhan CN, Johnsen JI, Kogner P (2010) Docosahexaenoic acid metabolome in neural tumors: identification of cytotoxic intermediates. FASEB J 24:906–915PubMedGoogle Scholar
  71. [71]
    Borkman M, Stolien LH, Pan DA, Jenkins AB, Chisholm DJ, Campbell LV (1993) The relation between insulin sensitivity and the fatty acid composition of skeletal muscle phospholipids. N Engl J Med 328:238–244PubMedGoogle Scholar
  72. [72]
    Das UN (2005) A defect in the activity of Δ6 and Δ5 desaturases may be a factor predisposing to the development of insulin resistance syndrome. Prostaglandins Leukot Essent Fatty Acids 72:343–350PubMedGoogle Scholar
  73. [73]
    Ginsberg BH, Jabour J, Spector AA (1982) Effect of alterations in membrane lipid unsaturation on the properties of the insulin receptor of Ehrlich ascites cells. Biochim Biophys Acta 690:157–164PubMedGoogle Scholar
  74. [74]
    Somova L, Moodley K, Channa ML, Nadar A (1999) Dose-dependent effect of dietary fish-oil (n-3) polyunsaturated fatty acids on in vivo insulin sensitivity in rat. Methods Find Exp Clin Pharmacol 21:275–278PubMedGoogle Scholar
  75. [75]
    Huang Y-J, Fang VS, Chou Y-C, Kwok C-F, Ho L-T (1997) Amelioration of insulin resistance and hypertension in a fructose-fed rat model with fish oil supplementation. Metabolism 46:1252–1258PubMedGoogle Scholar
  76. [76]
    Mori Y, Murakawa Y, Katoh S, Hata S, Yokoyama J, Tajima N, Ikeda Y, Nobukata H, Ishikawa T, Shibutani Y (1997) Influence of highly purified eicosapentaenoic acid ethyl ester on insulin resistance in the Otsuka Long-Evans Tokushima fatty rat, a model of spontaneous non-insulin dependent diabetes mellitus. Metabolism 46:1458–1464PubMedGoogle Scholar
  77. [77]
    Nobukata H, Ishikawa T, Obata M, Shibutani Y (2000) Long-term administration of highly purified eicosapenatenoic acid ethyl ester prevents diabetes and abnormalities of blood coagulation in male WBN/Kob rats. Metabolism 49:912–919PubMedGoogle Scholar
  78. [78]
    Demcakova E, Sebokova E, Ukropec J, Gasperikova D, Klimes I (2001) Delta-6 desaturase activity and gene expression, tissue fatty acid profile and glucose turnover rate in hereditary hypertriglyceridemic rats. Endocrinol Regul 35:179–186Google Scholar
  79. [79]
    Gasperikova D, Demcakova E, Ukropec J, Klimes I, Sebokova E (2002) Insulin resistance in the hereditary hypertriglyceridemic rat is associated with an impairment of delta-6 desaturase expression in liver. Ann N Y Acad Sci 967:446–453PubMedGoogle Scholar
  80. [80]
    Simoncikova P, Wein S, Gasperikova D, Ukropec J, Certik M, Klimes I, Sebokova E (2002) Comparison of the extrapancreatic action of gamma-linolenic acid and n-3 PUFAs in the high fat diet-induced insulin resistance. Endocr Regul 36:143–149PubMedGoogle Scholar
  81. [81]
    Bruning JC, Gautam D, Burks DJ, Gillette J, Schubert M, Orban PC, Klein R, Krone W, Muller-Wieland D, Kahn CR (2000) Role of brain insulin receptor in control of body weight and reproduction. Science 289:2122–2125PubMedGoogle Scholar
  82. [82]
    Hajnal A, Pothos EN, Lenard L, Hoebel BG (1998) Effects of feeding and insulin on extracellular acetylcholine in the amygdala of freely moving rats. Brain Res 785:41–48PubMedGoogle Scholar
  83. [83]
    Wang G-J, Volkow ND, Logan J, Pappas NR, Wong CT, Zhu W, Netusil N, Fowler JS (2001) Brain dopamine and obesity. Lancet 357:354–357PubMedGoogle Scholar
  84. [84]
    Li J, Zhang H, Wu F, Nan Y, Ma H, Guo W, Wang H, Ren J, Das UN, Gao F (2008) Insulin inhibits tumor necrosis factor-alpha induction in myocardial ischemia/reperfusion: role of Akt and endothelial nitric oxide synthase phosphorylation. Crit Care Med 36:1551–1558PubMedGoogle Scholar
  85. [85]
    Das UN (2000) Possible beneficial action(s) of glucose-insulin-potassium regimen in acute myocardial infarction and inflammatory conditions: a hypothesis. Diabetologia 43:1081–1082PubMedGoogle Scholar
  86. [86]
    Das UN (2001) Is insulin an anti-inflammatory molecule? Nutrition 17:409–413PubMedGoogle Scholar
  87. [87]
    Das UN (2001) Can glucose-insulin-potassium regimen suppress inflammatory bowel disease? Med Hypotheses 57:183–185PubMedGoogle Scholar
  88. [88]
    Das UN (2001) Hypothesis: can glucose-insulin-potassium regimen in combination with polyunsaturated fatty acids suppress lupus and other inflammatory diseases? Prostaglandins Leukot Essent Fatty Acids 65:109–113PubMedGoogle Scholar
  89. [89]
    Das UN (2002) Insulin and the critically ill. Crit Care 6:262–263PubMedGoogle Scholar
  90. [90]
    Das UN (2002) Is insulin an endogenous cardioprotector? Crit Care 6:389–393PubMedGoogle Scholar
  91. [91]
    Futerman AH, Banker GA (1996) The economics of neurite outgrowth: the addition of new membrane to growing axons. Trends Neurosci 19:144–149PubMedGoogle Scholar
  92. [92]
    Negre-Aminou P, Nemenoff RA, Wood MR, de la Houssaye BA, Pfenninger KH (1996) Characterization of phospholipase A2 activity enriched in the nerve growth cone. J Neurochem 67:2599–2608PubMedGoogle Scholar
  93. [93]
    Hornfelt M, Ekstrom PA, Edstrom A (1999) Involvement of axonal phospholipase A2 activity in the outgrowth of adult mouse sensory axons in vitro. Neuroscience 91:1539–1547PubMedGoogle Scholar
  94. [94]
    Kelly RB (1999) Deconstructing membrane traffic. Trends Cell Biol 9:M29–M33PubMedGoogle Scholar
  95. [95]
    Darios F, Davletov B (2006) Omega-3 and omega-6 fatty acids stimulate cell membrane expansion by acting on syntaxin 3. Nature 440:813–817PubMedGoogle Scholar
  96. [96]
    Rickman C, Davletov B (2005) Arachidonic acid allows SNARE complex formation in the presence of Munc18. Chem Biol 12:545–553PubMedGoogle Scholar
  97. [97]
    van der Wees J, Schilthuis JG, Koster CH, Diesveld-Schipper H, Folkers GE, van der Saag PT, Dawson MI, Shudo K, van der Burg B, Durston AJ (1998) Inhibition of retinoic acid receptor-mediated signalling alters positional identity in the developing hindbrain. Development 125:545–556PubMedGoogle Scholar
  98. [98]
    Mata de Urquiza A, Liu S, Sjoberg M, Zetterstrom RH, Griffiths W, Sjovall J, Perlmann T (2000) Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain. Science 290:2140–2144Google Scholar
  99. [99]
    Fan Y-Y, Spencer TE, Wang N, Moyer MP, Chapkin RS (2003) Chemopreventive n-3 fatty acids activate RXRα in colonocytes. Carcinogenesis 24:1541–1548PubMedGoogle Scholar
  100. [100]
    Lengqvist J, Mata de Urquiza, Bergman A-C, Willson TM, Sjovall J, Perlmann T, Griffiths W (2004) Polyunsaturated fatty acids including docosahexaenoic and arachidonic acid bind to the retinoid X receptor α ligand-binding domain. Mol Cell Proteomics 3:692–703PubMedGoogle Scholar
  101. [101]
    DeWille JW, Farmer SJ (1992) Postnatal dietary fat influences mRNAS involved in myelination. Dev Neurosci 14:61–68PubMedGoogle Scholar
  102. [102]
    Uauy R, Hoffman DR, Peirano P, Birch DG, Birch EE (2001) Essential fatty acids in visual and brain development. Lipids 36:885–895PubMedGoogle Scholar
  103. [103]
    Mohri I, Eguchi N, Suzuki K, Urade Y, Taniike M (2003) Hematopoietic prostaglandin D synthase is expressed in microglia in the developing postnatal mouse brain. Glia 42:263–274PubMedGoogle Scholar
  104. [104]
    Das UN (2009) Albumin and lipid enriched albumin for the critically ill. J Assoc Physicians India 57:53–58PubMedGoogle Scholar
  105. [105]
    Velasco A, Tabernero A, Medina JM (2003) Role of oleic acid as a neurotrophic factor is supported in vivo by the expression of GAP-43 subsequent to the activation of SREBP-1 and the up-regulation of stearoyl-CoA desaturase during postnatal development of the brain. Brain Res 977:103–111PubMedGoogle Scholar
  106. [106]
    Yavin E (2006) Versatile roles of docosahexaenoic acid in the prenatal brain: from pro- and anti-oxidant features to regulation of gene expression. Prostaglandins Leukot Essent Fatty Acids 75:203–211PubMedGoogle Scholar
  107. [107]
    Kuperstein F, Eilam R, Yavin E (2008) Altered expression of key dopaminergic regulatory proteins in the postnatal brain following perinatal n-3 fatty acid dietary deficiency. J Neurochem 106:662–671PubMedGoogle Scholar
  108. [108]
    Kuperstein F, Yakubov E, Dinerman P, Gil S, Eylam R, Salem N Jr, Yavin E (2005) Overexpression of dopamine receptor genes and their products in the postnatal rat brain following maternal n-3 fatty acid dietary deficiency. J Neurochem 95:1550–1562PubMedGoogle Scholar
  109. [109]
    Sinha RA, Khare P, Rai A, Maurya SK, Pathak A, Mohan V, Nagar GK, Mudiam MK, Godbole MM, Bandyopadhyay S (2009) Anti-apoptotic role of omega-3-fatty acids in developing brain: perinatal hypothyroid rat cerebellum as apoptotic model. Int J Dev Neurosci 27:377–383PubMedGoogle Scholar
  110. [110]
    Monroig O, Rotllant J, Sánchez E, Cerdá-Reverter JM, Tocher DR (2009) Expression of long-chain polyunsaturated fatty acid (LC-PUFA) biosynthesis genes during zebrafish Danio rerio early embryogenesis. Biochim Biophys Acta 1791:1093–1101PubMedGoogle Scholar
  111. [111]
    Kitajka K, Sinclair AJ, Weisinger RS, Weisinger HS, Mathai M, Jayasooriya AP, Halver JE, Puskas LG (2004) Effects of dietary omega-3 polyunsaturated fatty acids on brain gene expression. Proc Natl Acad Sci U S A 101:10931–10936PubMedGoogle Scholar
  112. [112]
    Kitajka K, Puskas LG, Zvara A, Hackler L, Barcelo-Coblijn G, Yeo YK, Farkas T (2002) The role of n-3 polyunsaturated fatty acids in brain: modulation of rat brain gene expression by dietary n-3 fatty acids. Proc Natl Acad Sci U S A 99:2619–2624PubMedGoogle Scholar
  113. [113]
    Barcelo-Coblijn G, Hogyes E, Kitajka LG, Zvara A, Hackler L Jr, Nyakas C, Penke Z, Farkas T (2003) Modification by docosahexaenoic acid of age-induced alterations in gene expression and molecular composition of rat brain phospholipids. Proc Natl Acad Sci U S A 100:11321–11326PubMedGoogle Scholar
  114. [114]
    Puskas LG, Kitajka K, Nyakas C, Barcelo-Coblijn G, Farkas T (2003) Short-term administration of omega 3 fatty acids from fish oil results in increased transthyretin transcription in old rat hippocampus. Proc Natl Acad Sci U S A 100:1580–1585PubMedGoogle Scholar
  115. [115]
    Galvin JE, Schuck TM, Lee VM, Trojanowski JQ (2001) Differential expression and distribution of alpha-, beta-, and gamma-synuclein in the developing human substantia nigra. Exp Neurol 168:347–355PubMedGoogle Scholar
  116. [116]
    Babcock TA, Helton WS, Anwar KN, Zhao YY, Espat NJ (2004) Synergistic anti-inflammatory activity of omega-3 lipid and rofecoxib pretreatment on macrophage proinflammatory cytokine production occurs via divergent NF-kappaB activation. JPEN J Parenter Enteral Nutr 28:232–239PubMedGoogle Scholar
  117. [117]
    Gronert K, Gewirtz A, Madara JL, Serhan CN (1998) Identification of a human enterocyte lipoxin A4 receptor that is regulated by interleukin (IL)-13 and interferon gamma and inhibits tumor necrosis factor alpha-induced IL-8 release. J Exp Med 187:1285–1294PubMedGoogle Scholar
  118. [118]
    Hinz B, Brune K, Pahl A (2003) 15-Deoxy-Delta(12,14)-prostaglandin J2 inhibits the expression of proinflammatory genes in human blood monocytes via a PPAR-gamma-independent mechanism. Biochem Biophys Res Commun 302:415–420PubMedGoogle Scholar
  119. [119]
    Berger A, Mutch DM, German JB, Roberts MA (2002) Dietary effects of arachidonate-rich fungal oil and fish oil on murine hepatic and hippocampal gene expression. Lipids Health Dis 1:2PubMedGoogle Scholar
  120. [120]
    Parrish WR, Rosas-Ballina M, Gallowitsch-Puerta M, Ochani M, Ochani K, Yang LH, Hudson L, Lin X, Patel N, Johnson SM, Chavan S, Goldstein RS, Czura CJ, Miller EJ, Al-Abed Y, Tracey KJ, Pavlov VA (2008) Modulation of TNF release by choline requires alpha7 subunit nicotinic acetylcholine receptor-mediated signaling. Mol Med 14:567–574PubMedGoogle Scholar
  121. [121]
    Hamano R, Takahashi HK, Iwagaki H, Yoshino T, Nishibori M, Tanaka N (2006) Stimulation of alpha7 nicotinic acetylcholine receptor inhibits CD14 and the toll-like receptor 4 expression in human monocytes. Shock 26:358–364PubMedGoogle Scholar
  122. [122]
    Yoshikawa H, Kurokawa M, Ozaki N, Nara K, Atou K, Takada E, Kamochi H, Suzuki N (2006) Nicotine inhibits the production of proinflammatory mediators in human monocytes by suppression of I-kappaB phosphorylation and nuclear factor-kappaB transcriptional activity through nicotinic acetylcholine receptor alpha7. Clin Exp Immunol 146:116–123PubMedGoogle Scholar
  123. [123]
    Borovikova LV, Ivanova S, Nardi D, Zhang M, Yang H, Ombrellino M, Tracey KJ (2000) Role of vagus nerve signaling in CNI-1493-mediated suppression of acute inflammation. Auton Neurosci 85:141–147PubMedGoogle Scholar
  124. [124]
    Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, Watkins LR, Wang H, Abumrad N, Eaton JW, Tracey KJ (2000) Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405:458–462PubMedGoogle Scholar
  125. [125]
    Flier MA, Rittirsch D, Nadeau BA et al (2007) Phagocyte-derived catecholamines enhance acute inflammatory injury. Nature 449:721–726Google Scholar
  126. [126]
    Stellwagen D, Malenka RC (2006) Synaptic scaling mediated by glial TNF-α. Nature 440:1054–1059PubMedGoogle Scholar
  127. [127]
    Beattie EC, Stellwagen D, Morishita W, Bresnahan JC, Ha BK, Von Zastrow M, Beattie MS, Malenka RC (2002) Control of synaptic strength by glial TNFα. Science 295:2282–2285PubMedGoogle Scholar
  128. [128]
    Hiramoto T, Chida Y, Sonoda J, Yoshihara K, Sudo N, Kubo C (2008) The hepatic vagus nerve attenuates Fas-induced apoptosis in the mouse liver via alpha7 nicotinic acetylcholine receptor. Gastroenterology 134:2122–2131PubMedGoogle Scholar
  129. [129]
    Lois C, Alvarez-Buylla A (1994) Long-distance neuronal migration in the adult mammalian brain. Science 264:1145–1148PubMedGoogle Scholar
  130. [130]
    Barinaga M (1997) Researchers find signals that guide young brain neurons. Science 278:385–386PubMedGoogle Scholar
  131. [131]
    Gage FH (1997) Mammalian neural stem cells. Science 287:1433–1438Google Scholar
  132. [132]
    Penninger JM, Woodgett J (2001) PTEN—coupling tumor suppression to stem cells? Science 294:2116–2118PubMedGoogle Scholar
  133. [133]
    Colombani J, Bianchini L, Layalle S, Pondeville E, Dauphin-Villemant C, Antoniewski C, Carre C, Noselli S, Leopold P (2005) Antagonistic actions of ecdysone and insulins determine final size in Drosophila. Science 310:667–670PubMedGoogle Scholar
  134. [134]
    Nisoli E, Tonello C, Cardile A, Cozzi V, Bracale R, Tedesco L, Falcone S, Valerio A, Cantoni O, Clementi E, Moncada S, Carruba MO (2005) Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS. Science 310:314–317PubMedGoogle Scholar
  135. [135]
    Chenn A, Zhang YA, Chang BT, McConnell SK (1998) Intrinsic polarity of mammalian neuroepithelial cells. Mol Cell Neurosci 11:183–193PubMedGoogle Scholar
  136. [136]
    Lien W-H, Klezovitch O, Fernandez TE, Delrow J, Vasioukhin V (2006) αE-catenin controls cerebral cortical size by regulating the hedgehog signaling pathway. Science 311:1609–1611PubMedGoogle Scholar
  137. [137]
    Castellone MD, Teramoto H, Williams BO, Druey KM, Gutkind JS (2005) Prostaglandin E2 promotes colon cancer growth through a Gs-axin-β-catenin signaling axis. Science 310:1504–1510PubMedGoogle Scholar
  138. [138]
    Cai J, Jiang WG, Mansel RE (1999) Inhibition of the expression of VE-cadherin/catenin complex by gamma linolenic acid in human vascular endothelial cells, and its impact on angiogenesis. Biochem Biophys Res Commun 258:113–118PubMedGoogle Scholar
  139. [139]
    Jiang WG, Hiscox S, Horrobin DF, Hallett MB, Mansel RE, Puntis MC (1995) Expression of catenins in human cancer cells and its regulation by n-6 polyunsaturated fatty acids. Anticancer Res 15:2569–2573PubMedGoogle Scholar
  140. [140]
    Carayol N, Vachier I, Campbell A, Crampette L, Bousquet J, Godard P, Chanez P (2002) Regulation of E-cadherin expression by dexamethasone and tumour necrosis factor-alpha in nasal epithelium. Eur Respir J 20:1430–1436PubMedGoogle Scholar
  141. [141]
    Lam TKT, Gutierrez-Juarez R, Pocai A, Rossetti L (2005) Regulation of blood glucose by hypothalamic pyruvate metabolism. Science 309:943–947PubMedGoogle Scholar
  142. [142]
    Woods SC, McKay LD (1978) Intraventricular alloxan eliminates feeding elicited by 2-deoxyglucose. Science 202:1209–1211PubMedGoogle Scholar
  143. [143]
    Woods SC, Lotter EC, McKay LD, Porte D Jr (1979) Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons. Nature 282:503–505PubMedGoogle Scholar
  144. [144]
    Rossetti L, Shulman GI, Zawalich W, Defronzo RA (1987) Effect of chronic hyperglycemia on in vivo insulin secretion in partially pancreatectomized rats. J Clin Invest 80:1037–1044PubMedGoogle Scholar
  145. [145]
    Mevorach M, Giacca A, Aharon Y, Hawkins M, Shamoon H, Rossetti L (1998) Regulation of endogenous glucose production by glucose per se is impaired in type 2 diabetes mellitus. J Clin Invest 102:744–753PubMedGoogle Scholar
  146. [146]
    Ikeda S, Kishida S, Yamamoto H, Murai H, Koyama S, Kikuchi A (1998) Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin. EMBO J 17:1371–1384PubMedGoogle Scholar
  147. [147]
    Itoh K, Krupnik VE, Sokol SY (1998) Axis determination in Xenopus involves biochemical interactions of axin, glycogen synthase kinase 3 and beta-catenin. Curr Biol 8:591–594PubMedGoogle Scholar
  148. [148]
    Aberle H, Bauer A, Stappert J, Kispert A, Kemler R (1997) Beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J 16:3797–3804PubMedGoogle Scholar
  149. [149]
    Fagotto F, Gluck U, Gumbiner BM (1998) Nuclear localization signal-independent and importin/karyopherin-independent nuclear import of beta-catenin. Curr Biol 8:181–190PubMedGoogle Scholar
  150. [150]
    Yost C, Farr GH III, Pierce SB, Ferke DM, Chen MM, Kimerlman D (1998) GBP, an inhibitor of GSK-3, is implicated in Xenopus development and oncogenesis. Cell 93:1031–1041PubMedGoogle Scholar
  151. [151]
    Brannon M, Gomperts M, Sumoy L, Moon RT, Kimelman D (1997) A beta-catenin/XTcf-3 complex binds to the siamois promoter to regulate dorsal axis specification in Xenopus. Genes Dev 11:2359–2370PubMedGoogle Scholar
  152. [152]
    Carron C, Pascal A, Djiane A, Boucaut J-C, Shi D-L, Umbhauer M (2003) Frizzled receptor dimerization is sufficient to activate the Wnt/β-catenin pathway. J Cell Sci 116:2541–2550PubMedGoogle Scholar
  153. [153]
    Haq S, Michael A, Andreucci M, Bhattacharya K, Dotto P, Walters B, Woodgett J, Kilter H, Force T (2003) Stabilization of β-catenin by a Wnt-independent mechanism regulates cardiomyocyte growth. Proc Natl Acad Sci U S A 100:4610–4615PubMedGoogle Scholar
  154. [154]
    Mikels AJ, Nusse R (2006) Purified Wnt5a protein activates or inhibits β-catenin-TCF signaling depending on receptor context. PLoS Biol 4:e115Google Scholar
  155. [155]
    He TC, Sparks AB, Rago C, Hermeking H, Zawel L, de Costa LT, Morin PJ, Vogelstein B, Kinzler KW (1998) Identification of c-MYC as a target of the APC pathway. Science 281:1509–1512PubMedGoogle Scholar
  156. [156]
    He TC, Chan TA, Vogelstein B, Kinzler KW (1999) PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell 99:335–345PubMedGoogle Scholar
  157. [157]
    Shtutman M, Zhurinsky J, Simcha I, Albanese C, D’Amico M, Pestell R, Bez-Ze’ev A (1999) The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci U S A 96:5522–5527PubMedGoogle Scholar
  158. [158]
    Tetsu O, McCormick F (1999) Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398:422–426PubMedGoogle Scholar
  159. [159]
    Howe LR, Subbaramaiah K, Chung WJ, Dannenberg AJ, Brown AMC (1999) Transcriptional activation of cyclooxygenase-2 in Wnt-1-transformed mouse mammary epithelial cells. Cancer Res 59:1572–1577PubMedGoogle Scholar
  160. [160]
    Howe LR, Crawford HC, Subbaramaiah K, Hassell JA, Dannenberg AJ, Brown AMC (2001) PEA3 is up-regulated in response to Wnt1 and activates the expression of cyclooxygenase-2. J Biol Chem 276:20108–20115PubMedGoogle Scholar
  161. [161]
    Haertel-Wiesmann M, Liang Y, Fantl WJ, Williams LT (2000) Regulation of cyclooxygenase-2 and periostin by Wnt-3 in mouse mammary epithelial cells. J Biol Chem 275:32046–32051PubMedGoogle Scholar
  162. [162]
    Xu HE, Lambert MH, Montana VG, Parks DJ, Blanchard SG, Brown PJ, Sternbach DD, Lehmann JM, Wisely GB, Willson TM, Kliewer SA, Milburn MV (1999) Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. Mol Cell 3:397–403PubMedGoogle Scholar
  163. [163]
    Nakamura T, Sano M, Songyang Z, Schneider MD (2003) A Wnt- and beta-catenin-dependent pathway for mammalian cardiac myogenesis. Proc Natl Acad Sci U S A 100:5834–5839PubMedGoogle Scholar
  164. [164]
    Salic A, Lee E, Mayer L, Kirschner MW (2000) Control of beta-catenin stability: reconsitution of the cytoplasmic steps of the wnt pathway in Xenopus egg extracts. Mol Cell 5:523–532PubMedGoogle Scholar
  165. [165]
    Hardt SE, Sadoshima J (2002) Glycogen synthase kinase-3veta: a novel regulator of cardiac hypertrophy and development. Circ Res 90:1055–1063PubMedGoogle Scholar
  166. [166]
    Phili-Couderc P, Pathak A, Smith F, Dambrin C, Harmancey R, Buys S, Galinier M, Massabuau P, Roncalli J, Senard J-M, Rouet P (2004) Uncomplicated human obesity is associated with a specific cardiac transcriptome: involvement of the Wnt pathway. FASEB J 18:1539–1540Google Scholar
  167. [167]
    Innis SM, de La Presa Owens S (2001) Dietary fatty acid composition in pregnancy alters neurite membrane fatty acids and dopamine in newborn rat brain. J Nutr 131:118–122PubMedGoogle Scholar
  168. [168]
    de La Presa Owens S, Innis SM (2000) Diverse, region-specific effects of addition of arachidonic and docosahexaenoic acids to formula with low or adequate linoleic and alpha-linolenic acids on piglet brain monoaminergic neurotransmitters. Pediatr Res 48:125–130PubMedGoogle Scholar
  169. [169]
    Helland IB, Smith L, Saarem K, Saugstad OD, Drevon CA (2003) Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children’s IQ at 4 years of age. Pediatrics 111:39–44Google Scholar
  170. [170]
    Whalley LJ, Fox HC, Wahle KW, Starr JM, Deary IJ (2004) Cognitive aging, childhood intelligence, and the use of food supplements: possible involvement of n-3 fatty acids. Am J Clin Nutr 80:1650–1657PubMedGoogle Scholar
  171. [171]
    Gustafsson PA, Duchen K, Birberg U, Karlsson T (2004) Breastfeeding, very long polyunsaturated fatty acids (PUFA) and IQ at 6 1/2 years of age. Acta Paediatr 93:1280–1287PubMedGoogle Scholar
  172. [172]
    Auestad N, Scott DT, Janowsky JS, Jacobsen C, Carroll RE, Montalto MB, Halter R, Qiu W, Jacobs JR, Connor WE, Connor SL, Taylor JA, Neuringer M, Fitzgerald KM, Hall RT (2003) Visual, cognitive, and language assessments at 39 months: a follow-up study of children fed formulas containing long-chain polyunsaturated fatty acids to 1 year of age. Pediatrics 112(3 Pt 1):e177–e183PubMedGoogle Scholar
  173. [173]
    Willatts P, Forsyth JS, DiModugno MK, Varma S, Colvin M (1998) Effect of long-chain polyunsaturated fatty acids in infant formula on problem solving at 10 months of age. Lancet 352:688–691PubMedGoogle Scholar
  174. [174]
    de La Presa Owens S, Innis SM (1999) Docosahexaenoic and arachidonic acid prevent a decrease in dopaminergic and serotoninergic neurotransmitters in frontal cortex caused by a linoleic and alpha-linolenic acid deficient diet in formula-fed piglets. J Nutr 129:2088–2093PubMedGoogle Scholar
  175. [175]
    Kuperstein F, Yakubov E, Dinerman P, Gil S, Eylam R, Salem N Jr, Yavin E (2005) Overexpression of dopamine receptor genes and their products in the postnatal rat brain following maternal n-3 fatty acid dietary deficiency. J Neurochem 95:1550–1562PubMedGoogle Scholar
  176. [176]
    Acar N, Chardigny JM, Berdeaux O, Alamnza S, Sebedio JL (2002) Modification of the monoaminergic neurotransmitters in frontal cortex and hippocampus by dietary trans alpha-linolenic acid in piglets. Neurosci Lett 331:198–202PubMedGoogle Scholar
  177. [177]
    Delion S, Chalon S, Guilloteau D, Besnard JC, Durand G (1996) Alpha-Linolenic acid dietary deficiency alters age-related changes of dopaminergic and serotoninergic neurotransmission in the rat frontal cortex. J Neurochem 66:1582–1591PubMedGoogle Scholar
  178. [178]
    Cunha RA, Ribeiro JA (1999) Facilitation of GABA release by arachidonic acid in rat hippocampal synaptosomes. Eur J Neurosci 11:2171–2174PubMedGoogle Scholar
  179. [179]
    Cheramy A, Artaud F, Godeheu G, L’hirondel M, Glowinski J (1996) Stimulatory effect of arachidonic acid on the release of GABA in matrix-enriched areas from the rat striatum. Brain Res 742:185–194PubMedGoogle Scholar
  180. [180]
    Nabekura J, Noguchi K, Witt MR, Neilsen M, Akaike N (1998) Functional modulation of human recombinant gamma-aminobutyric acid type A receptor by docosahexaenoic acid. J Biol Chem 273:11056–11061PubMedGoogle Scholar
  181. [181]
    Hamano H, Nabekura J, Nishikawa M, Ogawa T (1996) Docosahexaenoic acid reduces GABA response in substantia nigra neuron of rat. J Neurophysiol 75:1264–1270PubMedGoogle Scholar
  182. [182]
    Almeida T, Cunha RA, Ribeiro JA (1999) Facilitation by arachidonic acid of acetylcholine release from the rat hippocampus. Brain Res 826:104–111PubMedGoogle Scholar
  183. [183]
    Blanchet F, Gauchy C, Perez S, Glowinski J, Kemel ML (1999) Role of arachidonic acid in the regulation of the NMDA-evoked release of acetylcholine in striatal compartments. Synapse 31:140–150PubMedGoogle Scholar
  184. [184]
    Aid S, Vancassel S, Linard A, Lavialle M, Guesnet P (2005) Dietary docosahexaenoic acid [22:6(n-3)] as a phospholipid or a triglyceride enhances the potassium chloride-evoked release of acetylcholine in rat hippocampus. J Nutr 135:1008–1013PubMedGoogle Scholar
  185. [185]
    Minami M, Kimura S, Endo T, Hamaue N, Hirafuji M, Togashi H, Matsumoto M, Yoshioka M, Saito H, Watanabe S, Kobayashi T, Okuyama H (1997) Dietary docosahexaenoic acid increases cerebral acetylcholine levels and improves passive avoidance performance in stroke-prone spontaneously hypertensive rats. Pharmacol Biochem Behav 58:1123–1129PubMedGoogle Scholar
  186. [186]
    Zhang L, Reith ME (1996) Regulation of the functional activity of the human dopamine transporter by the arachidonic acid pathway. Eur J Pharmacol 315:345–354PubMedGoogle Scholar
  187. [187]
    L’hirondel M, Cheramy A, Godeheu G, Glowinski J (1995) Effects of arachidonic acid on dopamine synthesis, spontaneous release, and uptake in striatal synaptosomes from the rat. J Neurochem 64:1406–1409PubMedGoogle Scholar
  188. [188]
    Piomelli D, Pilon C, Giros B, Sokoloff P, Martres MP, Schwartz JC (1991) Dopamine activation of the arachidonic acid cascade as a basis for D1/D2 receptor synergism. Nature 353:164–167PubMedGoogle Scholar
  189. [189]
    Rodriguez Y, Christophe AB (2005) Long-chain omega6 polyunsaturated fatty acids in erythrocyte phospholipids are associated with insulin resistance in non-obese type 2 diabetics. Clin Chim Acta 354:195–199PubMedGoogle Scholar
  190. [190]
    Enriquez YR, Giri M, Rottiers R, Christophe A (2004) Fatty acid composition of erythrocyte phospholipids is related to insulin levels, secretion and resistance in obese type 2 diabetics on Metformin. Clin Chim Acta 346:145–152PubMedGoogle Scholar
  191. [191]
    Borkman M, Storlien LH, Pan DA, Jenkins AB, Chisholm DJ, Campbell LV (1993) The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids. N Engl J Med 328:238–244PubMedGoogle Scholar
  192. [192]
    Das UN, Vijay Kumar K, Krishna Mohan I (1994) Lipid peroxides and essential fatty acids in patients with diabetes mellitus and diabetic nephropathy. J Nutr Med 4:149–155Google Scholar
  193. [193]
    Warensjo E, Ohrvall M, Vessby B (2006) Fatty acid composition and estimated desaturase activities are associated with obesity and lifestyle variables in men and women. Nutr Metab Cardiovasc Dis 16:128–136PubMedGoogle Scholar
  194. [194]
    Ozanne SE, Martensz ND, Petry CJ, Loizou CL, Hales CN (1998) Maternal low protein diet in rats programmes fatty acid desaturase activities in the offspring. Diabetologia 41:1337–1342PubMedGoogle Scholar
  195. [195]
    Ohtani N, Ohta M, Sugano T (1997) Microdialysis study of modification of hypothalamic neurotransmitters in streptozotocin-diabetic rats. J Neurochem 69:1622–1628PubMedGoogle Scholar
  196. [196]
    Takahashi A, Ishimaru H, Ikarashi Y, Maruyama Y (1994) Aspects of hypothalamic neuronal systems in VMH lesion-induced obese rats. J Auton Nerv Syst 48:213–219PubMedGoogle Scholar
  197. [197]
    Barber M, Kasturi BS, Austin ME, Patel KP, Mohan Kumar SM, Mohan Kumar PS (2003) Diabetes-induced neuroendocrine changes in rats: role of brain monoamines, insulin and leptin. Brain Res 964:128–135PubMedGoogle Scholar
  198. [198]
    Bhattacharjee AK, Chang L, Lee HJ, Bazinet RP, Seemann R, Rapoport SI (2005) D2 but not D1 dopamine receptor stimulation augments brain signaling involving arachidonic acid in unanesthetized rats. Psychopharmacology (Berl) 180:735–742Google Scholar
  199. [199]
    Bouret SG, Draper SJ, Simerly RB (2004) Trophic action of leptin on hypothalamic neurons that regulate feeding. Science 304:108–110PubMedGoogle Scholar
  200. [200]
    Pinto S, Roseberry AG, Liu H, Diano S, Shanabrough M, Cai X, Friedman JM, Horvath TL (2004) Rapid rewiring of arcuate nucleus feeding circuits by leptin. Science 304:110–115PubMedGoogle Scholar
  201. [201]
    Cowley M, Smart JL, Rubenstein M, Cerdan MG, Diano S, Horvath TL, Cone RD, Low RD (2001) Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 411:480–484PubMedGoogle Scholar
  202. [202]
    Schwartz MW, Seeley RJ, Woods SC, Weigle DS, Campfield LA, Burn P, Baskin DG (1997) Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus. Diabetes 46:2119–2123PubMedGoogle Scholar
  203. [203]
    Stephens TW, Basinski M, Bristow PK, Bue-Valleskey JM, Burgett SG, Craft L, Hale J, Hoffmann J, Hsiung HM, Kriauciunas A et al (1995) The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 377:530–532PubMedGoogle Scholar
  204. [204]
    Pinto S, Roseberry AG, Liu H, Diano S, Shanabrough M, Cai X, Friedman JM, Horvath TL (2004) Rapid rewiring of arcuate nucleus feeding circuits by leptin. Science 304:110–115PubMedGoogle Scholar
  205. [205]
    Elmquist JK, Flier JS (2004) The fat-brain axis enters a new dimension. Science 304:63–64PubMedGoogle Scholar
  206. [206]
    Phipps K, Barker DJ, Hales CN et al (1993) Fetal growth and impaired glucose tolerance in men and women. Diabetologia 36:225–228PubMedGoogle Scholar
  207. [207]
    Barker DJ, Hales CN, Fall CH et al (1993) Type 2 (non-insulin dependent) diabetes mellitus, hypertension, and hyperlipidemia (syndrome X): relation to reduced fetal growth. Diabetologia 36:62–67PubMedGoogle Scholar
  208. [208]
    Lucas A, Fewtrell MS, Cole TJ (1999) Fetal origins of adult disease-the hypothesis revisited. BMJ 319:245–249PubMedGoogle Scholar
  209. [209]
    Das UN (1991) Essential fatty acids: biology and their clinical implications. Asia Pacific J Pharmacol 16:317–330Google Scholar
  210. [210]
    Das UN (1999) Essential fatty acids in health and disease. J Assoc Physicians India 47:906–911PubMedGoogle Scholar
  211. [211]
    Das UN (2006) Essential fatty acids-a review. Curr Pharm Biotechnol 7:467–482PubMedGoogle Scholar
  212. [212]
    Mercuri O, de Tomas E, Itarte H (1979) Prenatal protein depletion and δ9, δ6, and δ5 desaturases in the rat. Lipids 14:822–825PubMedGoogle Scholar
  213. [213]
    Trottier G, Koski KG, Brun T, Toufexis DJ, Richard D, Walker CD (1998) Increased fat intake during lactation modifies hypothalamic-pituitary-adrenal responsiveness in developing rat pups: a possible role for leptin. Endocrinology 139:3704–3711PubMedGoogle Scholar
  214. [214]
    Frederich RC, Hamann A, Anderson S, Lollmann B, Lowell BB, Flier JS (1995) Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med 1:1311–1314PubMedGoogle Scholar
  215. [215]
    Cha MC, Jones PJH (1998) Dietary fat type and energy restriction interactively influence plasma leptin concentrations in rats. J Lipid Res 39:1655–1660PubMedGoogle Scholar
  216. [216]
    Korotkova M, Gabrielsson B, Hanson LA, Strandvik B (2001) Maternal essential fatty acid deficiency depresses serum leptin levels in suckling rat pups. J Lipid Res 42:359–365PubMedGoogle Scholar
  217. [217]
    Korotkova M, Gabrielsson B, Hanson LA, Strandvik B (2002) Maternal dietary intake of essential fatty acids affects adipose tissue growth and leptin mRNA expression in suckling rat pups. Pediatr Res 52:78–84PubMedGoogle Scholar
  218. [218]
    Dhalgren J, Nilsson C, Jennische E et al (2001) Prenatal cytokine exposure results in obesity and gender-specific programming. Am J Physiol 281:E326–E334Google Scholar
  219. [219]
    Zahorska-Markiewicz B, Janowska J, Olszanecka-Glinianowicz M et al (2000) Serum concentrations of TNF-α and soluble TNF-α receptors in obesity. Int J Obes 24:1392–1395Google Scholar
  220. [220]
    Fried SK, Bunkin DA, Greenberg AS (1998) Omental and subcutaneous adipose tissues of obese subjects release interleukins-6: depot differences and regulation by glucocorticoid. J Clin Endocrinol Metab 83:847–850PubMedGoogle Scholar
  221. [221]
    Rask E, Walker BR, Soderberg S, Livingstone DEW, Eliasson M, Johnson O, Andrew R, Olsson T (2002) Tissue-specific changes in peripheral cortisol metabolism in obese women: increased 11β-hydroxysteroid dehydrogenase type 1 activity. J Clin Endocrinol Metab 87:3330–3336PubMedGoogle Scholar

Copyright information

© Springer Netherlands 2011

Authors and Affiliations

  1. 1.UND Life ScienceShaker HeightsUSA
  2. 2.School of BiotechnologyJawaharlal Nehru Technological UniversityKakinadaIndia

Personalised recommendations